148 related articles for article (PubMed ID: 6202143)
41. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study.
Lee AK; Rosen PP; DeLellis RA; Saigo PE; Gangi MD; Groshen S; Bagin R; Wolfe HJ
Am J Clin Pathol; 1985 Dec; 84(6):687-96. PubMed ID: 3878077
[TBL] [Abstract][Full Text] [Related]
42. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
Cerni C; Tatra G
Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191
[TBL] [Abstract][Full Text] [Related]
43. Editorial: When is a tumor marker not a tumor marker?
Vaitukaitis JL
N Engl J Med; 1975 Dec; 293(26):1370-1. PubMed ID: 52844
[No Abstract] [Full Text] [Related]
44. Oncofetal and oncoplacental antigens as tumor markers.
Yamauchi S; Miyake H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
[No Abstract] [Full Text] [Related]
45. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
46. The value of tumor markers in cancer of the ovary.
Cantarow WD; Stolbach LL; Bhattacharya M; Chatterjee SK; Barlow JJ
Int J Radiat Oncol Biol Phys; 1981 Aug; 7(8):1095-8. PubMed ID: 6170620
[No Abstract] [Full Text] [Related]
47. Markers in gynaecological cancer.
Bagshawe KD; Wass M; Searle F
Arch Gynecol; 1980; 229(4):303-10. PubMed ID: 7191243
[No Abstract] [Full Text] [Related]
48. Tumour antigens associated with primary mediastinal choriocarcinoma.
Forest JC; Talbot J; Pagé M; Loiselle JM
Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
[TBL] [Abstract][Full Text] [Related]
49. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
[TBL] [Abstract][Full Text] [Related]
50. Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa.
Hustin J
Gynecol Obstet Invest; 1978; 9(1):3-15. PubMed ID: 81793
[TBL] [Abstract][Full Text] [Related]
51. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
Kurman RJ; Ganjei P; Nadji M
Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
[No Abstract] [Full Text] [Related]
52. Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.
Gibbs AR; Harach R; Wagner JC; Jasani B
Thorax; 1985 Feb; 40(2):91-5. PubMed ID: 2579450
[TBL] [Abstract][Full Text] [Related]
53. [Serum markers in malignant diseases].
Peter HH
Med Lab (Stuttg); 1981 Nov; 34(11):262-71. PubMed ID: 6176842
[No Abstract] [Full Text] [Related]
54. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.
Bast RC; Klug TL; Schaetzl E; Lavin P; Niloff JM; Greber TF; Zurawski VR; Knapp RC
Am J Obstet Gynecol; 1984 Jul; 149(5):553-9. PubMed ID: 6204531
[TBL] [Abstract][Full Text] [Related]
55. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
56. Common epithelial ovarian tumors. Immunohistochemical intermediate filament profiles.
Dabbs DJ; Geisinger KR
Cancer; 1988 Jul; 62(2):368-74. PubMed ID: 2454722
[TBL] [Abstract][Full Text] [Related]
57. [An immunohistochemical study in conjunction with the enzyme labelled antibody method to discern the relevancy between the localization of hCG, hPL and the functions of the normal and malignant trophoblast (author's transl)].
Tanaka A
Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):579-88. PubMed ID: 6282995
[No Abstract] [Full Text] [Related]
58. Discrimination between benign, borderline, and malignant epithelial ovarian tumors using tumor markers: an immunohistochemical study.
Dietel M
Cancer Detect Prev; 1983; 6(1-2):255-62. PubMed ID: 6192920
[No Abstract] [Full Text] [Related]
59. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
[No Abstract] [Full Text] [Related]
60. Significance of tumour markers in ovarian cancer.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
